Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: Medical pharmaceuticals org | Vintage Vibes

3 Pharma Stocks to Buy in 2023 and Hold for Decades

The pharmaceutical industry is well-positioned for significant growth in the near future, given the growing demand for medicines and increasing R&D activities. Given the industry's inelastic demand, fundamentally strong pharma stocks AstraZeneca (AZN), Bristol-Myers Squibb (BMY), and GSK plc (GSK) might be solid long-term investments. Continue reading….

StockNews.com

3 Reliable Stocks That Could Help You Make Money in 2023

The stock market witnessed a decent rally in January, with cooling inflationary pressures reducing recession fears. However, the Fed’s attempts to bring inflation down to its 2% target could hurt economic growth. Hence, it could be wise to invest in shares of Johnson & Johnson (JNJ), Novartis (NVS), and LCNB…

StockNews.com

The Best Healthcare Stock on Wall Street to Buy Now

Pfizer (PFE) topped Wall Street’s EPS and revenue estimates in the third quarter. Moreover, the company updated its guidance for fiscal 2022. Analysts expect the stock to rise more than 16% in the near term. Therefore, it could be wise to buy the stock now. Keep reading….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

The 3 Best Large-Cap Stocks to Buy Now and Hold Forever

Although the latest inflation and employment reports indicate a resilient economy, the Fed’s persistence to keep interest rates high has caused widespread concerns about an economic slowdown. With uncertainties surrounding the economy, we think it could be wise to buy and hold large-cap stocks Merck & Co. (MRK), Coca-Cola (KO),…

StockNews.com

The #1 Pharma Stock to Buy in January 2023

While the stock market and the economy have been subdued by progressive interest-rate increases, AbbVie Inc. (ABBV) has not only reported a robust third quarter but also demonstrated its confidence in its long-term prospects by raising its quarterly dividend. Read on….

StockNews.com

The 3 Best Retirement Stocks to Buy for Investors Over 55

While moderation of the inflation rate is December has triggered a bear market rally, the stock market is unlikely to stabilize in the near term because of the likelihood of further interest rate hikes. Hence, shares of fundamentally strong and growing businesses with a track record of increasing dividend payouts,…

StockNews.com

3 Must Have Pharma Stocks in January 2023

Rising rates of chronic diseases, an aging population, and increasing healthcare spending should drive the pharma industry’s growth in the upcoming years. Moreover, pharma companies perform steadily regardless of economic conditions due to the inelastic demand for their products. Therefore, it could be wise to invest in fundamentally strong pharma…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

1 Dividend Stock to Buy Now and Retire on Later

Johnson & Johnson (JNJ) continued its business momentum in the third quarter of fiscal 2022, driven by steady demand for its products and innovative, advancing portfolio and pipeline. Moreover, the company has a record of raising its dividend for 60 consecutive years. Amid the current uncertain market conditions, this fundamentally…

StockNews.com

1 Pharma Stock That Could Head Even Higher Next Year

Pharma company Merck & Co. (MRK) is attempting to broaden its portfolio through collaborations and acquisitions. The company looks poised for growth in 2023. So, the stock might be a solid buy now. Read on….

StockNews.com

3 Stocks to Buy to Build a Millionaire Portfolio

Inflation eased for the second consecutive month in November, and the Fed slowed down the pace of rate hikes after four straight 75-basis-point hikes. However, recession fears loom as the central bank plans to raise rates through next year. Regardless of the economic uncertainties, it could be wise to invest…

StockNews.com

The Best Medical Stock to Buy Right Now for Under $100

Despite macroeconomic challenges, leading pharma company Bristol-Myers Squibb (BMY) has the robustness and resilience to deliver value for shareholders. Read on….

StockNews.com

1 Stock That Could Easily Beat the Market Over the Next 5 Years

Pfizer (PFE) benefited substantially from the COVID-19 pandemic. It pays a more than 3% dividend, making it attractive for investors looking for stable income. The stock has picked up steady momentum, and its robust fundamentals should help the company easily outpace the market in the coming years. Let’s discuss this…

StockNews.com

The Best Blue-Chip Stock to Buy for 2023 and Beyond

Pharmaceutical giant Johnson & Johnson (JNJ) topped consensus estimates in the last quarter. Shares of this well-established blue-chip company are all set to weather the possible market volatility next year. Read on….

StockNews.com

The Best Pharma Stock to Buy in December 2022

Pharma company Bristol-Myers Squibb (BMY) is working on strengthening its pipeline and has raised its annual dividend recently. Hence, the stock might be a solid addition to your portfolio this month. Read on….

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

1 Pharma Stock to Buy for Under $1 This December

Pharma company Rigel’s (RIGL) REZLIDHIA recently achieved the U.S. Food and Drug Administration’s approval for treating relapsed or refractory acute myeloid leukemia, helping the stock to soar. RIGL shares have gained more than 30% over the past month. Given the industry tailwinds, RIGL might be the ideal stock to buy…

StockNews.com

This 1 Stock Can Weather Any Recession

Pfizer (PFE) has been a COVID beneficiary and is expected to continue to gain from its vaccines as the pandemic war is yet to be over. Moreover, PFE offers a more than 3% dividend. Thus, investors might consider buying this quality stock which seems well-positioned to weather any recession. Keep…

StockNews.com

Is It Too Late to Get in on the Upward Move in This Medical Stock?

Despite economic uncertainties, leading pharma company Bristol-Myers Squibb (BMY) beat street estimates in the fiscal third quarter with solid financials. However, given the current market turmoil, is it too late to get on the upward move in this stock? Continue reading to find out.

StockNews.com

Is Merck & Co. Stock Worth Buying Before the End of 2022?

Healthcare company Merck & Co. (MRK) is set to acquire Imago BioSciences (IMGO) for more than $1 billion. The stock has gained more than 40% this year. However, given the macroeconomic headwinds, would it be wise to buy the stock now? Read on to find out….

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

1 Stock to Buy Now That Could Make You Rich in 2023

Biopharmaceutical major Bristol-Myers Squibb Company (BMY) beat the consensus earnings and revenue estimates in the third quarter. Given its strong product pipeline, strategic acquisitions, discounted valuation, high profitability, strong financials, and attractive dividends, investors could buy the stock now. Read more….

StockNews.com

1 No-Brainer Stock to Buy That Could Help You Retire Earlier

Biopharma giant AbbVie (ABBV) is well-placed to gain from its drug pipeline, recent drug approvals, and strategic acquisitions. Given its strong fundamentals, discounted valuation, high profitability, reliable dividends, and favorable analyst estimates, investing in this stock could help you retire earlier. Read more.

StockNews.com

1 Stock That's Always a Safe Bet Amid Market Volatility

Leading healthcare company Johnson & Johnson (JNJ) has been able to navigate the volatile market conditions due to the defensive nature of its business and solid fundamentals. Moreover, the company has an impressive history of increasing its dividends. Given JNJ’s robust financials, high profitability, and consistent dividend payouts, we think…

StockNews.com

4 Health Care Stocks That Could Keep Your Portfolio From Needing a Check-Up

The healthcare industry tends to withstand macroeconomic pressure better than other industries due to the almost inelastic demand for medical products and services. With a recession expected next year, investors could look to capitalize on the defensive characteristics and long-term prospects of the industry by investing in quality medical stocks…

StockNews.com

Hot Stocks to Buy? 3 Medical Stocks to Consider Now

The healthcare industry tends to withstand challenging macro conditions relatively well, as it enjoys inelastic demand for its products and services. And given the solid long-term prospects of the industry, it could be wise to load up fundamentally sound medical stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck (MRK)…

StockNews.com

This Health Care Stock Is a No-Brainer Buy for Fall

Merck & Co.’s (MRK) third-quarter financials surpassed Wall Street’s expectations. The stock is trading near its 52-week high of $101.50, and its momentum is expected to continue, considering its strong fundamentals. Given the company’s solid growth, reliable dividend payments, and the resilience of its sector against the expected economic slowdown,…

StockNews.com

3 Stocks That Are Great for Passive Income Investors

Though the U.S. economy bounced back after shrinking in the first half of the year, falling consumer spending and the rate hikes to tame high inflation might lead the economy into a recession. Hence, investors looking for passive income could invest in fundamentally sound dividend-paying stocks Pfizer (PFE), Sanofi (SNY),…

1 2 3

People

Kritika SarmahHer

727 stories

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

595 stories

Santanu RoyHaving

215 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.